Phio Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -1 | -1,477 | -1,181 |
EBITDA | -4,002 | -2,370 | -2,390 |
EBIT | -4,003 | -2,371 | -2,392 |
Net Income | -4,003 | -2,371 | -2,392 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -4,003 | -2,079 | -2,092 |
Cash | 17,031 | 21,031 | 10,705 |
Basic Shares | 11,617 | 11,617 | 5,468 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -4,618 | -3,643 | -6,332 | -193 |
EBITDA | -8,695 | -7,148 | -10,642 | -11,269 |
EBIT | -8,698 | -7,150 | -10,826 | -11,462 |
Net Income | -8,698 | -7,150 | -10,826 | -11,305 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,991 | -7,113 | -10,754 | -12,250 |
Cash | 21,031 | 5,382 | 8,490 | 11,781 |
Basic Shares | 5,984 | 787 | 231 | 126 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.36 |
2026-03-31 | -$0.34 |
2025-12-31 | -$0.15 |
2025-09-30 | -$0.44 |